Treatment outcome and prognostic factors in patients with carcinoma of the anal canal

任骅,景灏,金晶,李晔雄,王维虎,王淑莲,宋永文,刘跃平,房辉

DOI: https://doi.org/10.3760/cma.j.issn.1004-4221.2013.04.002

2013-01-01

Abstract:Objective To retrospectively analyze the treatment outcome and prognostic factors in patients with primary carcinoma of the anal canal (CAC).Methods From January 2000 to December 2011,31 patients with CAC were treated in our institution; of the 31 patients,23 had squamous cell carcinoma,and 8 had adenocarcinoma.In the initial treatment for stage Ⅰ—Ⅲ patients,16 were treated with radiotherapy-based modality,11 with surgery-based modality,and 3 with chemotherapy.Results The follow-up rate was 90％ ;21 patients were followed up for at least 3 years.The 3-year overall survival (OS) rate and progression-free survival (PFS) rate were 76％ and 56％,respectively.The univariate analysis showed that clinical stage and T stage were the prognostic factors for OS (x2 =12.11,P =0.001 ; x2 =4.64,P =0.031) and marginal prognostic factors for PFS (x2 =2.91,P =0.088;x2 =2.75,P =0.097).There were no significant differences in 3-year OS and PFS between the stage Ⅰ —Ⅲ patients with squamous cell carcinoma who received radiotherapy-based initial treatment and those who received surgery-based initial treatment (80％ vs.80％,x2 =0.08,P =0.776 ;78％ vs.67％,x2 =0.17,P =0.697).Of the patients treated with radiotherapy,37％ experienced grade 3 acute skin or mucosal toxicity,and 9％ experienced impaired anal sensation or function as late toxicity.Conclusions Clinical stage and T stage are the most important prognostic factors in patients with CAC.Concurrent chemoradiotherapy should be the standard radical treatment for squamous cell carcinoma of the anal canal,and using intensity-modulated radiotherapy helps patients to complete the planned course of radiotherapy without severe adverse events.